The antineoplastic drug cis-diamminedichloroplatinum(II) (cisplatin, CDDP) is an extremely active drug in the treatment of patients with disseminated testicular germ cell tumours. Over 80% of these patients can be cured with a CDDP-containing drug regimen (Loehrer and Einhorn, 1984) . In contrast, no cures can be obtained with this compound in patients with colon cancer and most other solid tumours (Loehrer and Einhorn, 1984) . Understanding of CDDP sensitivity and resistance has predominantly come from the stsudy of cell lines selected for CDDP resistance by in vitro drug incubations (for review see Andrews and Howell, 1990) . These studies revealed several causes for CDDP resistance. Relevant mechanisms are decreased cellular accumulation of CDDP, increased detoxification, by either the glutathione (GSH) or the metallothionein system, and enhanced DNA repair, often resulting in decreased DNA platination (for review see Andrews and Howell, 1990) . In most cases of in vitro acquired CDDP resistance, a combination of these factors is found. Unselected cell lines may provide a cellular model of drug resistance that is more representative of the clinical situation. Bedford et al. (1988) previously used germ cell and bladder tumour cell lines as the CDDP-sensitive and -resistant representatives of a model. In that study, a correlation of CDDP sensitivity with platinum (Pt) accumulation and deficient DNA damage repair in one of the two germ cell cell lines was found. In general, for germ cell tumour cell lines a greater sensitivity to CDDP has been reported compared with cell lines derived from other solid tumour types (Oosterhuis et al., 1984; Pera et al., 1987; Walker et al., 1987; Bedford et al., 1988; Parris et al., 1990; Kelland et al., 1992; Masters et al., 1993; Hill et al., 1994) .
In the present study parameters potentially relevant to CDDP sensitivity were examined in three germ cell tumour and three colon carcinoma cell lines, as their original tumours reflect extremely sensitive and resistant tumour types. Cellular detoxification mechanisms, Pt accumulation, DNA platination and repair and the nuclear enzymes DNA topoisomerase (topo) I and II were compared as they may contribute to cellular CDDP sensitivity. In order to achieve a good definition of the model, basic cellular characteristics of the cell lines were also determined.
Materials and methods
CDDP was obtained from Bristol-Myers (Weesp, The Netherlands) and RPMI-1640 medium, Leibovitz L15 medium and fetal calf serum (FCS) from Life Technologies (Paisley, UK). GSH, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium, sodium pyruvate, protease XXIV and propidium iodide were purchased from Sigma (St Louis, MO, USA). 5-Bromo-2'-deoxyuridine was obtained from Serva (Heidelberg, Germany), rabbit anti-mouse immunoglobulin [F(ab)2 fragments, fluorescein conjugated] from Dakopatts (Glostrup, Denmark), glutamine from Flow Laboratories (Irvine, UK) and diaminobenzoic acid from Fluka (Buchs, Germany). Nuclease P1 and DNAse I were purchased from Boehringer Mannheim (Almere, The Netherlands).
For the cell lines used in this study, origin and pretreatment were as described in Table I . The subclone NTera2/D1 (Tera; Timmer-Bosscha et al., 1993) of Tera-2 (Fogh, 1978) , 833 KE (Bronson et al., 1980) and Scha (Andrews et al., 1987) were used as germ cell tumour cell lines and Colo 320 (Quin et al., 1979 ), SW 948 (Leibovitz et al., 1976 , and Caco-2 (Fogh et al., 1977) chemotherapy Fogh et al. (1977) cultures with protease XXIV for 10 min. Scha and Colo 320 were harvested by gentle shaking. All cell lines were cultured at 37°C in a humidifed atmosphere with 5% carbon dioxide. CDDP sensitivity was analysed with the microculture tetrazolium assay as described previously (Timmer-Bosscha et al., 1989) . Before the assays were performed, the linear relationship of cell number to formazan crystal formation was checked and cell growth studies were performed. Each cell line was seeded at optimum density in order to test survival after at least two or three cell divisions had taken place in the control cells. This was day 4 for Tera, 833 KE, Scha and Colo 320 and day 6 for SW 948 and Caco-2. For Tera, 833 KE and Scha 1 x 104, 1.5 x 104 and 3 x 104 cells, respectively, were incubated continuously with a range of CDDP concentrations, in a total volume of 0.2 ml of culture medium in 96-well plates. For Colo 320, SW 948 and Caco-2, 2.5 x 103, 5 X 103 and 1 x I04 cells, respectively were incubated continuously in a total volume of 0.1 ml. A minimum of three experiments per cell line was performed, each in quadruplicate.
Population doubling time during log phase was determined by cell count in a haemocytometer with trypan blue dye exclusion as a measure of viability. Experiments were repeated three times for each cell line. Cell cycle distribution was determined according to Preisler et al. (1992) . In brief, exponentially growing cells were incubated with 10 LM 5-bromo 2'-deoxyuridine for 30 min, washed with phosphatebuffered saline (PBS; 0°C) and fixed in 70% ethanol (0°C). Cells were resuspended in hydrochloric acid of a molarity that gave optimal results (Tera, 833 KE, Scha and Colo 320, all 2.5 M; SW 948 and Caco-2, 3 M), subsequently incubated with anti-5-bromo 2'-deoxyuridine monoclonal antibody, a second antibody [rabbit anti-mouse/F(ab) Lowry et al. (1951) . For nuclear protein determination cell nuclei were isolated as described by De Jong et al. (1990) and total nuclear protein contents were determined according to Bradford (1976) . For both protein determinations three or more separate experiments were performed for each cell line. DNA content was measured in 0.5 x 106 cells by the diaminobenzoic acid assay (Kissane and Robins, 1958) . In each assay a standard curve with salmon sperm DNA in 1 M ammonium hydroxide was included. A minimum of three separate experiments for each cell line were performed.
The conditions and measurements for GSH, total sulphydryl content (TSH) and glutathione S-transferase (GST) activity in the cell lines were as described previously (Hospers et al., 1988) Reported values are the mean of three independent experiments. The amount of GST7 isoenzyme was determined in all lines using sodium dodecyl sulphate-polyacrylamide gel electrophoresis followed by Western blotting and subsequent incubation with a monoclonal antibody raised against GSTic (Peters et al., 1989 (Peters et al., , 1992 . For each line the expression was determined in three independent cell protein extracts.
The topo I and II catalytic activities were determined in 0.35 M sodium chloride nuclear extracts of cells in the logarithmic phase of growth by relaxation of supercoiled PBR 322 (topo I) and the decatenation assay (topo II), with 270, 90, 30, 10, 3, 1 and 0.3 ng of protein, as described previously (De Jong et al., 1990) . Experiments were performed in triplicate, while the small-cell lung cancer cell line, GLC4, was included as a reference (De Jong et al., 1990) .
For determination of cellular Pt content, 5 x 106 cells of each cell line were incubated for 4 h at 37°C with CDDP concentrations ranging from 33 to 100 M. After washing three times with PBS (0°C) pellets were dissolved in 0.5 ml 65% nitric acid in an oven at 70°C for 2 h. Thereafter the Pt content was determined by atomic absorption spectrophotometry (AAS) as described previously (Hospers et al., 1988) . At each CDDP concentration experiments were performed in triplicate or quadruplicate. For measurements of Pt bound to DNA a total of 5 x 107 cells of each cell line was treated with CDDP concentrations ranging from 33 to 1I00 lM for 4 h at 37°C. Cells were washed three times with PBS (0°C). DNA was isolated and the amounts of DNA and Pt were measured as described previously (Hospers et al., 1988) . At each CDDP concentration experiments were performed in quadruplicate. The kinetics of Pt bound to total nuclear DNA were determined after a 4 h incubation of 108 cells with 16.5 LM CDDP in germ cell tumour cell lines. After incubation with 16.5 itM, Pt bound to DNA in the Tera cells was at the detection limit of the AAS. A main drawback of this dose was that it was 7-24 times the ICso of the germ cell tumour cell lines. In order not to favour the colon carcinoma cell lines in this respect, the colon carcinoma cell lines were incubated with 33 .LM CDDP (4-8 times their ICW). Incubation of the colon carcinoma cell lines with a higher CDDP concentration was avoided as it would lead to too high a level of Pt binding to DNA and therefore would invalidate the comparison. Immediately after incubation (t = 0) one part of each sample was washed with PBS (0C, three times); in the other part medium was refreshed and cells were kept at 37°C for 24 h and then washed with PBS (t = 24) as above. Both parts were further processed for measurement of Pt bound to DNA. In order to decrease sample viscosity for Pt and DNA measurements, DNA was digested by nuclease P1 (7.8 jig 10-6 cells) and DNAse I (8.4 U 10-6 cells) in a buffer containing 10 mM Tris, 4 mM magnesium chloride, 0.1 mM EDTA and 0.24 mM zinc sulphate. Pt amount in these samples was measured as described previously (Hospers et al., 1988) In Table II (Table III) was not significantly lower in the germ cell tumour than in the colon carcinoma cell lines. But GSH levels of the six cell lines were positively correlated with CDDP ICs (r = 0.90, P < 0.05). Surprisingly, TSH levels showed an inverse correlation with CDDP IC50 (r = -0.94, P <0.05). There was also a significant difference between both groups of cell lines with respect to TSH (P <0.025) ( Table III) . GST activity and the amount of GSTx (Table III) ( Table IV) . Values shown in Table IV Andrews and Howell, 1990) . But the role of metallothioneins in the CDDP sensitivity of tumour cells has been mainly established in cell lines in which metallothionein has been induced with other heavy metals (for review see Andrews and Howell, 1990) . However, the role of metallothioneins in CDDP resistance seems complex. Recently, it has been reported that in Chinese hamster ovary cells transient induction of constitutive metallothionein leads to decreased CDDP sensitivity (Koropatnick and Pearson, 1993) . In contrast, in the same cell line, overexpression of a transfected mouse metallothionein gene leads to an increased CDDP sensitivity (Koropatnick and Pearson, 1993) . In the present model higher amounts of TSH were found in the germ cell tumour cell lines than in the colon carcinoma lines. In view of the data of Koropatnick and Pearson (1993) Andrews and Howell, 1990) . However, in our study no direct correlation of GST activity with CDDP sensitivity was observed. In the analysis of variance, GST activity in combination with GSH level and Pt bound to DNA showed a correlation with CDDP sensitivity at IC50. This is compatible with a role of GST in cellular detoxification in these cell lines. There was no difference between both groups of cell lines with respect to GST activity of amount of GSTrc. However, the GST activity in colon carcinomas is generally reported to be increased (Moscow et al., 1989; Peters et al., 1992) , while in germ cell tumours GST activity is decreased compared with normal adjacent tissue (Strohmeyer et al., 1992 Decrease of cellular Pt uptake in cells with in vitro acquired resistance is a frequent mechanism of resistance (for review see Gately and Howell, 1993) , and the amount of Pt bound to DNA in tumour cells in vitro is often correlated with CDDP sensitivity (Sherman and Lippard, 1987 CDDP followed by 24 h culture offered a good correlation (Bedford et al., 1988) . In contrast, Hill et al. (1994) found the lowest DNA platination in the most sensitive lines and the highest in the most insensitive lines, using a panel of four germ cell tumour cell lines and an incubation and postincubation scheme according to Bedford et al. (1988) . In our model cellular Pt uptake did not correlate with sensitivity. The germ cell tumour cell line Scha, for example, had a high cellular Pt level, while the most sensitive germ cell tumour cell line, Tera, had a low cellular Pt content. Pt bound to DNA did not correlate with sensitivity unless combined with parameters of cellular detoxification. This is surprising as Pt binding to DNA is usually considered to be the mechanism of toxicity of CDDP. Correlation with Pt bound to DNA at t= 24 h was found in the group of germ cell tumour cell lines, but not in the group of colon carcinoma cell lines. An increase in Pt-DNA levels during the 24-h post-incubation period was also found in two of the germ cell tumour cell lines described by Hill et al. (1994) . As that study used an immunochemical technique whereas the present study used AAS to measure Pt-DNA, it is unlikely that this increase is due to an artifact of the technique used. The fact that we also found increases in Pt bound to DNA in one colon carcinoma and no repair in another seemed contrary to the results reported by Bedford et al. (1988) . In that study the resistant cell line was incubated with a concentration of CDDP close to its own ICm. In our study the resistant cell lines were incubated with CDDP concentrations exceeding their IC50 by 4-to 8-fold. In these circumstances a lack of repair capacity is also found in the colon carcinoma cell lines. This suggested that the lack of repair capacity described for germ cell tumour cell lines (Bedford et al., 1988; Kelland et al., 1992; Hill et al., 1994 ) might be at least partly due to the high incubation concentrations relative to their IC50 values in the studies described, and not only to a unique phenomenon in germ cell tumour cell lines.
Analysis of variance was used to correlate combinations of parameters with sensitivity. It showed a good correlation between IC50, the parameter normally used to indicate drug sensitivity, and Pt bound to DNA in combination with GSH and GST activity. However, at other cytotoxicity levels (IC1o and IC90) also, combined correlations with other parameters such as topo II activity, cellular Pt content and TSH were found. The diversity of correlations might indicate that in these cell lines different mechanisms may be important at different levels of sensitivity, although since only a few cell lines were analysed the results can only be used as a guideline. The fact that at all cytotoxicity levels one or more components of the detoxifying system are involved is a strong indication for the relevance of this system in intrinsic tumour cell CDDP sensitivity. On the other hand, the contribution of a certain parameter in the various cell lines might vary widely. For instance, in the germ cell tumour cell line Scha, the GSH level was similar to that in the colon carcinoma cell line SW 948. But the high Pt accumulation in Scha seemed to overwhelm its GSH pool, leading to a higher Pt-DNA binding (t= 0) in Scha than in SW 948 after incubation with the same CDDP concentration. The colon carcinoma cell line Caco-2 exhibited a high degree of Pt accumulation but a low level of Pt-DNA binding. This might be caused by a high efficacy of its detoxifying system, as GSH levels and GST activity were the highest in this cell line.
Based on our model of unselected cell lines it can be concluded that multiple parameters must be analysed to explain CDDP resistance in vitro. However, other parameters that we did not include in this study (for review see Kelland, 1994) might explain the sensitivity of germ cell tumour and the insensitivity of colon carcinoma cell lines. Thus the sensitivity of germ cell tumours to a range of drugs inducing DNA damage and the possible role of DNA damage recognition proteins (McLaughlin et al., 1993) are intriguing.
In conclusion, the study described here did not reveal a cause of the unique sensitivity of germ cell tumours, but the unexpected relation between ICso and TSH should be studied further.
Abbrevations: AAS, atomic absorption spectrophotometry; CDDP, cisplatin, cis-diamminedichloroplatinum(II); CDNB, 1-chloro-2,4-dinitrobenzene; FCS, fetal calf serum; GSH, glutathione; GST, glutathione S-transferase; ICIO, drug concentration inhibiting survival by 10%; IC"0, drug concentration inhibiting survival by 50%; IC90, drug concentration inhibiting survival by 90%; PBS, phosphatebuffered saline (0.14 M sodium chloride, 2.7 mm potassium chloride, 6.4 mM disodium hydrogen phosphate, 1.5 mm potassium dihydrogen phosphate, pH 7.4); Pt, platinum; topo, DNA topoisomerase; TSH, total sulphydryl content.
